US Broker Ratings

Pharvaris N.V. (PHVS) Stock Analysis: Potential 53.84% Upside Amidst Promising Rare Disease Therapies

Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is making waves in the healthcare sector with its innovative approach to treating rare diseases. Specializing in the development..

Septerna, Inc. (SEPN) Investor Outlook: Biotechnology Player with a 71.74% Upside Potential

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is attracting considerable attention in the healthcare sector. With a market capitalization of $629.54 million, the company is..

Trevi Therapeutics, Inc. (TRVI) Investor Outlook: Eyeing a Promising 184.92% Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a clinical-stage biopharmaceutical company that has been capturing investor attention with its promising therapeutic developments and significant growth potential. With..

REGENXBIO Inc. (RGNX) Stock Analysis: 215% Potential Upside Ignites Investor Interest

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, is capturing the attention of investors with a striking potential upside of 215.82%. Operating in the healthcare sector,..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: Exploring a 26.88% Potential Upside

Amylyx Pharmaceuticals, Inc. (AMLX) is capturing the attention of investors eager to tap into the promising biotechnology sector. Headquartered in Cambridge, Massachusetts, Amylyx is a clinical-stage..

Bioventus Inc. (BVS) Stock Analysis: Exploring 79.58% Potential Upside and Analyst Consensus

Bioventus Inc. (NASDAQ: BVS), a healthcare company specializing in medical devices, is drawing attention for its significant potential upside as reflected in recent analyst ratings. With..

Investor Outlook for Xencor, Inc. (XNCR): Analyzing the 187.93% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) stands out in the biopharmaceutical landscape, offering investors a unique opportunity in the healthcare sector. With a market capitalization of $596.97 million,..

Surmodics, Inc. (SRDX) Stock Analysis: Insights Into a Challenging Valuation Landscape

Surmodics, Inc. (NASDAQ: SRDX), a notable player in the healthcare sector with a focus on medical devices, offers a unique mix of opportunities and challenges for..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Growth in the Volatile Diagnostics Sector

Myriad Genetics, Inc. (NASDAQ: MYGN) is a notable player in the healthcare sector, specializing in molecular diagnostic testing and precision medicine. Despite the company’s compelling innovation..

Verastem, Inc. (VSTM) Stock Analysis: Biotech Firm with Over 46% Potential Upside

Verastem, Inc. (NASDAQ: VSTM), a promising player in the biotechnology sector, is capturing investor attention due to its significant potential upside of 46.78%. With a current..

Weave Communications, Inc. (WEAV) Stock Analysis: Unveiling a 61% Potential Upside in the Health Information Space

Weave Communications, Inc. (NASDAQ: WEAV) is positioning itself as a formidable player in the health information services sector. With its innovative customer experience and payments software..

Cogent Biosciences (COGT) Stock Analysis: A 63% Potential Upside with Strong Buy Ratings

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its promising pipeline in precision therapies for genetically defined diseases. With a market capitalization of $1.81..

Talkspace, Inc. (TALK) Investor Outlook: Analyzing an 82% Potential Upside in the Virtual Healthcare Space

As the digital transformation of healthcare continues to gain momentum, Talkspace, Inc. (NASDAQ: TALK) emerges as a compelling contender in the virtual behavioral healthcare sector. With..

Maravai LifeSciences Holdings (MRVI): Navigating the Biotech Landscape with a 74.79% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, is attracting significant attention from investors due to its robust potential upside. With..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Resilient Free Cash Flow

Investors with an eye on the healthcare sector may find Avanos Medical, Inc. (NYSE: AVNS) an intriguing prospect despite its current challenges. Operating within the medical..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Potential 240% Upside in the Biotech Sphere

Investors with an eye for opportunities in the biotechnology sector may find Relay Therapeutics, Inc. (NASDAQ: RLAY) an intriguing prospect. With a market capitalization of $689.64..

MBX Biosciences, Inc. (MBX): Investor Outlook Reveals 191.91% Potential Upside with Promising Pipeline

MBX Biosciences, Inc. (MBX) is carving a niche in the healthcare sector, specifically within the biotechnology industry, focusing on precision peptide therapies for endocrine and metabolic..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotechnology Sector with Strategic Collaborations

Fortrea Holdings Inc. (FTRE), a burgeoning player in the biotechnology sector, presents a mixed bag of prospects for investors. With a market capitalization of $954.31 million,..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Financial Challenges

Sonida Senior Living, Inc. (SNDA) operates within the Healthcare sector, focusing on providing comprehensive senior housing solutions in the United States. This Dallas-based company, founded in..

KalVista Pharmaceuticals, Inc. (KALV) Consensus: A Biotech Gem with Over 108% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), an emerging biopharmaceutical company in the healthcare sector, is drawing significant attention from investors with its promising drug pipeline and remarkable..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds